FDA approves first treatment for thyroid eye disease
The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED). Approval was granted to Viridian Therapeutics.
Jul 7, 2026
0
7
MeSH tree: C23.888.592.763.941.339
The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED). Approval was granted to Viridian Therapeutics.
Jul 7, 2026
0
7
Gazing at smartphone screens for even one hour a day can cause digital eye strain, especially when scrolling through social media. According to a new study published in the Journal of Eye Movement Research, it is not just ...
Most patients with thyroid eye disease treated with teprotumumab didn't require additional treatment nearly two years later, according to industry-supported research being presented Sunday at ENDO 2024, the Endocrine Society's ...
Jun 2, 2024
0
37
Lasik eye surgery is a common vision-correcting procedure that many Americans view as safe and effective, but the U.S. Food and Drug Administration has now drafted guidance that warns of potential complications.
Dec 8, 2022
0
49
The visual pathway is very long and goes from the eyes to the occipital lobe, which is the region in the cerebral hemisphere that processes vision. Since the visual pathway goes through the cerebral hemisphere on each side, ...
Aug 2, 2022
0
276